Yes — DexScreener is completely free to use in 2026. No subscription, no account required, no hidden fees. Here is everything you get at zero cost.
DexScreener is fully free to use. The platform provides access to real-time DEX data across 100+ blockchains, the full token screener, price alerts, portfolio tracker, watchlist, new pairs feed and trending data all without any subscription fee or account requirement. DexScreener monetizes primarily through the boosted tokens advertising program, allowing the core analytics platform to remain free for all users.
The most powerful free DEX analytics platform — real-time charts, 100+ chains, token screener, alerts and portfolio tracker in one place.
Charts, screener, alerts, portfolio, watchlist and new pairs — all DexScreener core features are free without any payment.
Access DexScreener without creating an account. Create a free account only if you want cross-device sync for watchlist and alerts.
Unlike some competitors DexScreener does not require you to hold any token to access features. Everything is free without conditions.
DexScreener API is free for individual developers without requiring an API key or subscription for the public endpoints.
Follow these steps to get the most out of DexScreener.
Did not believe DexScreener was truly free at first. Tested every feature expecting a paywall. Screener, alerts, portfolio, API — all genuinely free. Remarkable what they offer at zero cost.
Cancelled my paid DEX analytics subscription after discovering DexScreener. The free features exceed what I was paying for elsewhere. Sometimes free really is better.
DexScreener API free tier is incredibly generous. Built a production trading tool without paying anything. The data quality and reliability are excellent for a free service.
Track any token on 100+ blockchains in real time. No registration, no fees. Just open DexScreener and start trading smarter.
This is an independent guide and not affiliated with DexScreener. Crypto trading involves significant risk. Always do your own research. Past performance is not indicative of future results.